Although no statistical significance of ACSL4 expression for recurrence-free survival (HR: 1.663, 95% CI: 0.921–3.004, p = 0.092, Table 3) was indicated, patients with high expression levels of ACSL4 were demonstrated a trend for HCC recurrence. Here, ACSL4 is linked to hepatocellular carcinoma.